Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Radical Surgery Best for Most Rectal Cancers

By HospiMedica International staff writers
Posted on 16 Jun 2011
A new study recommends that local resection of rectal cancer should be reserved only for superficial tumor stage 1 (T1) disease in patients who will comply with aggressive postoperative surveillance. More...


Researchers at Massachusetts General Hospital (Boston, MA, USA) and the University of Amsterdam (the Netherlands) reviewed the records of 109 consecutive patients with preoperative imaging results suggestive of T1 or T2 disease who underwent total mesorectal excision. All patients underwent preoperative endorectal ultrasonography (US) or magnetic resonance imaging (MRI) and computed tomography (CT), with or without positron emission tomography. Final pathologic investigation identified T3 disease in 27 of the patients. History, physical examination results, and radiologic and pathologic data were evaluated for predictors of positive nodes in the remaining 82 patients.

The results showed that despite indications of negative nodes on radiographic examination, 4 of 35 patients with T1 disease (11%) and 13 of 47 with T2 disease (28%) had positive nodes. The only significant predictor was depth of invasion: 24 of 65 patients with negative nodes (37%) versus 13 of 17 patients with positive nodes (76%) had tumors invading the lower third of the submucosa and beyond. Endorectal US, MRI, and CT (with or without positron emission tomography) used for preoperative staging could not identify these patients reliably. In addition, histologic markers of aggressive disease were not helpful. The study was published in the May 2011 issue of Archives of Surgery.

"Negative results of imaging can be falsely reassuring; because patients with local recurrence have survival rates of 43% to 58% after salvage operations, we believe that local resection should be performed only for superficial T1 tumors, preferably using transanal endoscopic microsurgery, in patients who will adhere to aggressive postoperative surveillance," concluded lead author Harry Salinas, MD, and colleagues of the department of surgery.

Local resection of T1 and T2 rectal cancer results in lower morbidity compared with radical resection. However, recurrence rates after local resection are higher, likely owing to unresected nodal metastasis.

Related Links:
Massachusetts General Hospital
University of Amsterdam



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.